Anna Orduña Dolado on Muck Rack

Anna Orduña Dolado

As seen in: Wiley Online Library, JAMA Network
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anna Orduña

Contact Anna Orduña, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease

|
By Gemma Salvadó, Kanta Horie, Nicolas Barthelemy, Nicolas R. Barthélemy, Suzanne Schindler, Shorena Janelidze, Anna Orduña Dolado, Divya Bali, Richard Perrin, JOHN MORRIS, Brian Gordon, Erik Stomrud, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Jacob Vogel, Randall J. Bateman, Rik Ossenkoppele, Oskar Hansson, Tammie L. S. Benzinger
| JAMA Network
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease Supplement 1. eTable 1. Demographic Characteristics of Knight ADRC Participants eTable 3. Confusion Matrices of Plasma-Based Stages Against PET-Based Stages in Each Subsample eTable 4. Statistics PET-Based Stages vs Plasma-Based Stages eTable 5. Cross-Sectional Differences in AD Biomarkers in BioFINDER-2 eTable 6. Differences in Longitudinal Changes in AD Biomarkers in BioFINDER-2 eTable 7.
Open in Who Shared Issue with article?

A comparison of p‐tau assays for the specificity to detect tau changes in Alzheimer's disease

|
By Shorena Janelidze, Nicholas Ashton, Ulrika Nordstrom, Anna Orduña Dolado
| Wiley Online Library
1 BACKGROUND Cerebrospinal fluid (CSF) tests for amyloid beta (Aβ) peptides (Aβ42 and Aβ40) and phosphorylated tau-181 (p-tau181) have been used for several decades as biomarkers of Alzheimer's disease (AD).1 More recently, CSF p-tau181/Aβ42 and Aβ42/Aβ40 were approved by the U.S. Food and Drug Administration (FDA) to diagnose AD.2-4 Furthermore, during the past 4 years, blood-based p-tau biomarkers of AD (and p-tau217, in particular) have been applied extensively in research settings and...
Open in Who Shared View Duplicates (1) Issue with article?
See all 2 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Anna Orduña

Contact Anna Orduña, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified